Friday, February 2, 2024

The Gist Healthcare Podcast
02/02/2024 8 min
Friday, February 2, 2024

Listen "Friday, February 2, 2024"

Descargar episodio Ver en sitio original

Episode Synopsis

Biogen will stop selling its Alzheimer’s drug, Aduhelm, amid controversy. The Biden Administration makes its initial offers to drug companies on the first ten drugs to be negotiated through Medicare, as courts weigh lawsuits brought by pharmaceutical companies challenging the negotiation process. And, participation in Medicare accountable care organizations is up. That’s coming up on today’s episode of Gist Healthcare Daily. Hosted on Acast. See acast.com/privacy for more information.
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA